TO

Tuyen Ong

VC Partner, CEO Partner at Flagship Pioneering

Location

United States, North America

Check Size

$500K - $15M

Investment Stage

Series B

Focus Areas

BioTech
Enterprise
Pharmaceuticals

About Investor

Tuyen Ong is a CEO-Partner at Flagship Pioneering, investing primarily in Series B life sciences and biotech ventures, with typical checks ranging between $500K and $15M. His most recent investment, Ring Therapeutics, focuses on next-generation gene therapy using commensal virome vectors. He draws from a strong pharmaceutical and biotech background, having previously served as SVP and Head of Ophthalmology at Biogen and as Chief Development Officer at Nightstar Therapeutics.

Looking for investors like Tuyen Ong?
Get matched with the right ones for your startup.

Explore more investors

Previous investments

Ring Therapeutics
87M |2023
120M |2021

Similar Investors

RF

Riley Florsheim

United States, North America
$100K - $5M

Pre Seed

,

Seed

,
FF

Faraz Fatemi

United States, North America
$1M - $30M

Seed

,

Series A

,
VL

Vishal Lugani

United States, North America
$700K - $7M

Seed

,

Series A

,
CG

Chian Gong

United States, North America
$250K - $10M

Pre Seed

,

Seed

,
GR

Gokul Rajaram

United States, North America
$25K - $1M

Pre Seed

,

Seed

,
WC

Wayne Chang

United States, North America
$10K - $500K

Pre Seed

,

Seed

,

Is this You?

Is this you? Have any edits?
Fill out our update request form and we'll update ASAP

Grow with the Right Investors

This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.

Start Matching For Free